Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. The company employs 27 full-time employees The company went IPO on 2025-01-15. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.
HKPD stock price ended at $0.62 on 金曜日, after dropping 3.13%
On the latest trading day May 08, 2026, the stock price of HKPD fell by 3.13%, dropping from $0.59 to $0.62. During the session, the stock saw a volatility of 25.00%, with prices oscillating between a daily low of $0.56 and a high of $0.70. On the latest trading day, the trading volume for HKPD decreased by 29.4K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 16.5K shares were traded, with a market value of approximately $14.5M.